Brown M A, Corrigan A B
Rheumatology Department, Repatriation General Hospital Concord, NSW.
Med J Aust. 1991 Oct 7;155(7):493-4. doi: 10.5694/j.1326-5377.1991.tb93850.x.
Pancytopenia is an unusual complication of low-dose methotrexate therapy in rheumatoid arthritis. We report a near fatal case that followed an accidental overdose.
An 80-year-old Caucasian woman with rheumatoid arthritis presented with pancytopenia and severe mucositis. She had taken her weekly methotrexate dose on four sequential days, due to an error in filling a "Dosette" box.
Following treatment with piperacillin, gentamicin and folinic acid, she recovered completely.
Low-dose methotrexate therapy is uncommonly associated with haematological toxicity. This generally occurs in patients with known risk factors for such reactions. Patient reliability should be considered if methotrexate therapy is contemplated.
全血细胞减少是类风湿关节炎低剂量甲氨蝶呤治疗中一种不常见的并发症。我们报告一例因意外过量用药导致的近乎致命的病例。
一名80岁患类风湿关节炎的白种女性出现全血细胞减少和严重的粘膜炎。由于“多剂量药盒”装药错误,她连续四天服用了每周的甲氨蝶呤剂量。
经哌拉西林、庆大霉素和亚叶酸治疗后,她完全康复。
低剂量甲氨蝶呤治疗罕见地与血液学毒性相关。这通常发生在有此类反应已知危险因素的患者中。如果考虑采用甲氨蝶呤治疗,应考虑患者的依从性。